Oxford Immunotec and Lophius Biosciences Sign Licensing and Collaboration Agreements

News   Jan 29, 2013

 
Oxford Immunotec and Lophius Biosciences Sign Licensing and Collaboration Agreements
 
 
 

RELATED ARTICLES

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

APEIRON Strengthens Management Board

News

Industry expert Peter Llewellyn-Davies joins as New Chief Financial Officer.

READ MORE

Psilocybin for Treatment-Resistant Depression

News

Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE